The medical device and healthtech products market is growing faster than any other segment of the healthcare industry. In fact, it’s expected to double in size by 2025, accounting for 10% of all healthcare spending that year. We also see…
It is amazing how time flies, and here we are at the Jewish new year again. As one year ends and we transition into another, we take this opportunity to send our wishes for a sweet, healthy and successful new…
September, 2022 Aurore ANDRE, CEO of Azapharm joins the strategic board of Apmonia Therapeutics, a biotechnology company dedicated to developing anti-cancer immunotherapy strategies. Apmonia’s strategic board comprises experts in biotech, business, funding and more, who harness their experience to support the company’s innovation and growth. “I am pleased…
A recent article, posted on Linkedin by Aurore Andre, CEO of Azapharm reviews the use of Artificial Intelligence in healthcare: pros, cons and the path forward. Artificial intelligence is one of the fastest-growing industries, with sector funding up by 108%…
It's been a challenging year for everyone, but as the Beatles said "Here comes the sun, and I say it's all right". As we're getting ready to celebrate Passover, the holiday of spring and freedom, we wish you and your…
Digital communication is never as easy as it sounds. It’s not all about social media and content marketing. It is not about your website and the newsletters you send. These are all just tools. Digital communication is first and foremost…
![[Infographic] Introducing The HealthTech Ecosystems Of Israel & France](https://www.azapharm.com/wp-content/uploads/2021/03/IL_FR_Healthtech_Ecosystem_Comparison-Infographic_header.jpg)
2020 has been an eventful year for everyone but more so for the healthcare and healthtech sectors. We at Azapharm, have been keeping a close eye on the two ecosystems we are most close to and work with: Israel and…
After an 11th hour deal struck for the next European Union budget by its 27 members on 10th December 2020, Horizon Europe, the EU’s latest research and innovation investment programme can at last be launched next month. Originally touted at…
The festive season is upon us and for all our dear friends, partners, collaborators and colleagues, we wish that the roller coaster ride that has been 2020, comes to an end and that we all have some time to relax.…
